Treatment of alcohol use disorder in patients with liver disease.
作者信息
Hill Gordon S, Cohen Shawn M, Weimer Melissa B
机构信息
Department of Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
出版信息
Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0217. doi: 10.1097/CLD.0000000000000217. eCollection 2024 Jan-Jun.
Abstract
摘要
相似文献
1
Treatment of alcohol use disorder in patients with liver disease.肝病患者酒精使用障碍的治疗。
Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0217. doi: 10.1097/CLD.0000000000000217. eCollection 2024 Jan-Jun.
2
N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.N-乙酰半胱氨酸治疗肝病患者酒精使用障碍：进一步研究的理由。
Expert Opin Investig Drugs. 2018 Aug;27(8):667-675. doi: 10.1080/13543784.2018.1501471. Epub 2018 Aug 1.
3
Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease.酒精使用障碍的多学科视角：从一种精神疾病到一种主要的肝脏疾病
Biomolecules. 2016 Jan 15;6(1):11. doi: 10.3390/biom6010011.
4
Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.巴氯芬用于治疗肝硬化患者酒精使用障碍：首个证据出现10年后
Front Psychiatry. 2018 Oct 1;9:474. doi: 10.3389/fpsyt.2018.00474. eCollection 2018.
5
The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial.肝脏护理试验——对酒精使用障碍治疗患者进行肝病筛查：一项随机对照可行性试验。
Pilot Feasibility Stud. 2024 May 16;10(1):78. doi: 10.1186/s40814-024-01504-5.
6
Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models.酒精使用障碍和酒精相关肝病管理障碍：实施综合护理模式的策略。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):186-195. doi: 10.1016/S2468-1253(21)00191-6.
7
Screening, Diagnosis, and Treatment of Alcohol-Related Liver Disease and Alcohol-Associated Hepatitis.酒精性肝病和酒精性肝炎的筛查、诊断与治疗
Gastroenterol Hepatol (N Y). 2022 Jul;18(7):409-417.
8
Therapeutic Pipeline in Alcohol-Associated Liver Disease.酒精相关性肝病的治疗药物研发管线。
Semin Liver Dis. 2023 Feb;43(1):60-76. doi: 10.1055/s-0042-1759614. Epub 2022 Dec 26.
9
Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease.缩小治疗差距：酒精性肝病患者酒精使用障碍的管理
Clin Ther. 2023 Dec;45(12):1189-1200. doi: 10.1016/j.clinthera.2023.09.017. Epub 2023 Dec 4.
10
Management of Alcohol Use Disorder in Patients With Alcoholic Liver Disease.酒精性肝病患者酒精使用障碍的管理
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1514-1526. doi: 10.1016/j.jceh.2022.04.010. Epub 2022 Apr 18.
本文引用的文献
1
Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.酒精使用障碍的药物治疗：系统评价和荟萃分析。
JAMA. 2023 Nov 7;330(17):1653-1665. doi: 10.1001/jama.2023.19761.
2
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.用于治疗酒精使用障碍的药物可改善有危险饮酒和酒精相关肝硬化患者的生存。
Hepatol Commun. 2023 Mar 24;7(4). doi: 10.1097/HC9.0000000000000093. eCollection 2023 Apr 1.
3
Integrating Alcohol-Related Prevention and Treatment Into Primary Care: A Cluster Randomized Implementation Trial.将酒精相关预防和治疗纳入初级保健：一项集群随机实施试验。
JAMA Intern Med. 2023 Apr 1;183(4):319-328. doi: 10.1001/jamainternmed.2022.7083.
4
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.纳曲酮治疗酒精使用障碍：有无肝病患者的肝脏安全性。
Hepatol Commun. 2022 Dec;6(12):3433-3442. doi: 10.1002/hep4.2080. Epub 2022 Oct 25.
5
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis.酒精使用障碍与肝病的同步管理：一项系统评价与荟萃分析。
J Addict Med. 2023;17(2):e119-e128. doi: 10.1097/ADM.0000000000001084. Epub 2022 Oct 8.
6
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.酒精使用障碍治疗后与酒精相关的肝病的发生率和进展。
JAMA Netw Open. 2022 May 2;5(5):e2213014. doi: 10.1001/jamanetworkopen.2022.13014.
7
The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.物质使用障碍的管理：2021 年美国退伍军人事务部和美国国防部临床实践指南概要。
Ann Intern Med. 2022 May;175(5):720-731. doi: 10.7326/M21-4011. Epub 2022 Mar 22.
8
Alcoholics Anonymous and other 12-step programs for alcohol use disorder.戒酒互助会及其他针对酒精使用障碍的12步康复计划。
Cochrane Database Syst Rev. 2020 Mar 11;3(3):CD012880. doi: 10.1002/14651858.CD012880.pub2.
9
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis.酒精使用障碍治疗对肝硬化患者临床结局的影响。
Hepatology. 2020 Jun;71(6):2080-2092. doi: 10.1002/hep.31042. Epub 2020 May 22.
10
Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016.美国成年人酒精性脂肪肝疾病的患病率，2001-2016 年。
JAMA. 2019 May 7;321(17):1723-1725. doi: 10.1001/jama.2019.2276.
Zotero 插件